Should the usual threshold for prostate biopsy be lowered from 4.0 to 2.5 ng/mL for healthy men with a life expectancy of well over 10 years?

Share this article:

The National Cancer Institute estimated that 240,890 men would be diagnosed with prostate cancer in the United States in 2011. Many clinicians believe the disease is being overdiagnosed and overtreated, yet some researchers have advocated decreasing the PSA threshold for prostate biopsy from the conventional 4.0 ng/mL to 2.5 ng/mL in an attempt to pick up prostate cancers that are now being missed. Critics say this could exacerbate the problem of overdiagnosis and lead to even more men being treated unnecessarily.

Renal & Urology News would like to know what you think, so please answer the following poll question.

Leave a comment below on why you chose your answer. If your answer doesn't match one of our choices, please let us know why.

Share this article:
You must be a registered member of RUN to post a comment.

Sign Up for Free e-newsletters

More in Physician Polls

How often do you try to persuade your patients who smoke to give up the habit?

How often do you try to persuade your ...

Doctors can play an important role in educating patients who smoke about the adverse health effects.

Is allowing patients direct access to lab results a good idea?

Is allowing patients direct access to lab results ...

A ruling from the HHS took effect allowing patients direct access to medical laboratory results.

Will Google Glass become standard use in the operating room?

Will Google Glass become standard use in the ...

Google Glass affords new opportunities for surgeons and other healthcare professionals.